norm: tetraphase pharmaceuticalsUSLEI 529900BOHW16K9S8NC02 · no CIKMax severity: Medium↳ subsidiary of Innoviva, Inc.

Canonical registry

TETRAPHASE PHARMACEUTICALS, INC.

ent_01a00d26a57e6104737d8da2b14baa8c

Compliance scorecard →View in feed →

Disclosures

1

State AG · 1 jurisdiction

Multi-filing incidents

—

no multi-filing incident in sample

Max affected reported

2

as filed · State AG MA

Leak-site claims

0

none in sample

Identity resolution

Canonical name: TETRAPHASE PHARMACEUTICALS, INC.
Normalized: tetraphase pharmaceuticals— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 529900BOHW16K9S8NC02
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record
Corporate parent: Innoviva, Inc.— per SEC Exhibit 21 filing

Disclosure history (1)newest first

Massachusetts State AGas victim2019-10-22
Tetraphase Pharmaceuticals, Inc. reported a data breach to the Massachusetts Office of Consumer Affairs and Business Regulation. The breach was reported on 2019-10-22. 2 Massachusetts residents were affected. The report records the breach type as electronic.